Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Nasdaq Returns to 5,000 for First Time in 15 Years
49:44 - March 2 -- The Nasdaq composite briefly touched above the 5,000 mark today for the first time in 15 years. Bloomberg’s Scarlet Fu looks back on changes in the market during that time. She speaks on “Market Makers.”
  • Buffett Protects Berkshire From `Short-Termism': Russo
  • How Do Banks Fit in the Future of Mobile Payments?
  • HP Buying Aruba Networks in $2.7 Billion Deal